Monday, February 19, 2018

BRIEF-AstraZeneca ‍Says US FDA Approves Imfinzi For Unresectable Stage III Non-Small Cell Lung Cancer​

* ‍US FDA APPROVES IMFINZI FOR UNRESECTABLE STAGE III NON-SMALL CELL LUNG CANCER​
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)